Of importance, LepR is therapeutically targetable as overexpression of LepR rescues the inhibitory effect of leptin on SLE Tfh cell differentiation, and blocks IgG autoantibody production in humanized lupus chimeras. This evidence concerns the gene LEP and systemic lupus erythematosus.